Howe Jolanda 4
4 · Mirum Pharmaceuticals, Inc. · Filed Aug 8, 2025
Insider Transaction Report
Form 4
Howe Jolanda
SVP, GLOBAL CONTROLLER
Transactions
- Exercise/Conversion
Common Stock
2025-08-07$6.27/sh+10,000$62,700→ 12,426 total - Sale
Common Stock
2025-08-07$58.00/sh−10,000$580,000→ 2,426 total - Exercise/Conversion
Employee Stock Option (right to buy)
2025-08-07−10,000→ 40,000 totalExercise: $6.27Exp: 2029-05-13→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on December 16, 2024.
- [F2]The stock option is fully vested.